Back to Newsroom

Immunexpress to Present Data on the Early Diagnosis of Sepsis with SeptiCyte® Lab at the Next Generation Diagnostics Summit

SEATTLE, Aug. 12, 2015 –  Immunexpress, Inc. today announced that Dr. Therese Seldon, Vice President of Operations, will present data on the utility of its SeptiCyte® Lab test to aid in the clinical assessment of sepsis in critical care patients at the Next Generation Diagnostics Summit on Aug. 19 in Washington, D.C. The presentation will include data from a large, prospective, multisite study.

Click here to read more